Login / Signup

Potential benefit and lack of serious risk from corticosteroids in drug-induced liver injury: An international, multicentre, propensity score-matched analysis.

Hao NiuJiayi MaInmaculada Medina-CalizMercedes Robles-DiazElvira BonillaMarwan S GhabrilMaría Isabel LucenaIsmael Alvarez-AlvarezRaúl Jesús Andrade
Published in: Alimentary pharmacology & therapeutics (2022)
Corticosteroid therapy did not worsen outcome in DILI patients. Indeed, corticosteroid administration was associated with a greater rate of normalisation of liver enzymes in patients with serious DILI.
Keyphrases
  • drug induced
  • end stage renal disease
  • newly diagnosed
  • chronic kidney disease
  • peritoneal dialysis
  • clinical trial
  • cross sectional
  • risk assessment
  • adverse drug
  • human health